ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Topic: Novartis

U.S. sues Novartis over alleged fraudulent kickbacks

U.S. sues Novartis over alleged fraudulent kickbacks

April 23, 2013 4:56 pm by | 0 Comments

(Reuters) - Novartis AG was sued on Tuesday by the United States, which accused the Swiss drug maker of using kickbacks to induce pharmacies to steer thousands of patients to ... Read more
Big Pharma down, not out, after Indian patent blow

Big Pharma down, not out, after Indian patent blow

April 2, 2013 10:53 am by | 0 Comments

LONDON/MUMBAI (Reuters) - Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to ... Read more
India’s top court dismisses Novartis petition for Glivec patent

India’s top court dismisses Novartis petition for Glivec patent

April 1, 2013 1:17 am by | 0 Comments

NEW DELHI (Reuters) - India's highest court has dismissed Swiss drugmaker Novartis AG's petition seeking patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms which ... Read more
Novartis says Alcon’s eye drug Jetrea gets EU approval

Novartis says Alcon’s eye drug Jetrea gets EU approval

March 18, 2013 3:10 am by | 0 Comments

ZURICH (Reuters) - Novartis said its Alcon unit got a green light from the European Commission for Jetrea, a drug that treats an eye condition that can lead to blindness.Jetrea ... Read more
FDA panel: Calcitonin salmon doesn’t help osteoporosis

FDA panel: Calcitonin salmon doesn’t help osteoporosis

March 5, 2013 5:18 pm by | 0 Comments

March 5 (Reuters) - A panel of advisers to the U.S. Food and Drug Administration recommended on Tuesday that the agency no longer support the marketing of calcitonin salmon as ... Read more
EU approves Novartis drug for gout that blocks interleukin-1 beta

EU approves Novartis drug for gout that blocks interleukin-1 beta

March 1, 2013 1:35 am by | 0 Comments

ZURICH (Reuters) - The European Commission has approved Novartis' drug Ilaris for patients with an often painful form of inflammatory arthritis, the drugmaker said on Friday.Novartis said the EU had ... Read more
Drugmakers eye Africa’s middle classes as next growth market

Drugmakers eye Africa’s middle classes as next growth market

February 12, 2013 2:30 am by | 0 Comments

For pharmaceutical companies, Africa is changing.

Not only is the continent's economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is luring Big Pharma, as new ... Read more

Study: Ritalin treats apathy in patients with Alzheimer’s disease

Study: Ritalin treats apathy in patients with Alzheimer’s disease

January 31, 2013 7:49 am by | 0 Comments

Leslye Nathe did not realize the profound effect that Ritalin was having on her mother's Alzheimer's disease until a doctor stopped the prescription.Her mother, Susan Brown, 74, a resident at ... Read more
FDA head and company CEOs cheer bumper haul of new drugs

FDA head and company CEOs cheer bumper haul of new drugs

January 25, 2013 1:33 pm by | 0 Comments

* Approvals in past 2 years "cause for optimism" -FDA head* Scientific progress, better diagnostics help productivity* Pick-up follows lean period for drug industry R&D labsDAVOS, Switzerland, Jan 25 (Reuters) ... Read more
Novartis CEO tempers talk of Roche stake sale

Novartis CEO tempers talk of Roche stake sale

January 25, 2013 3:30 am by | 0 Comments

DAVOS, Switzerland (Reuters) - Novartis Chief Executive Joe Jimenez played down talk that it was looking to sell its one-third voting stake in crosstown rival Roche, and certainly not at ... Read more
Novartis withdraws marketing application for Ruvise

Novartis withdraws marketing application for Ruvise

January 24, 2013 11:09 am by | 0 Comments

LONDON (Reuters) - Swiss drugmaker Novartis has withdrawn a marketing application for its drug Ruvise, designed to treat arterial hypertension, the European Medicines Agency (EMA) said on Thursday.The drug, known ... Read more
Novartis expects sales to grow from 2014

Novartis expects sales to grow from 2014

January 23, 2013 11:14 am by | 0 Comments

ZURICH (Reuters) - Novartis expects sales to grow in the mid-single digits from 2014 once it has absorbed the full impact of competition from cheaper drugs, and said its long-standing ... Read more
Novartis: Trial results back show Tasigna is better than Glivec for myeloid leukemia

Novartis: Trial results back show Tasigna is better than Glivec for myeloid leukemia

December 10, 2012 4:33 pm by | 0 Comments

ZURICH (Reuters) - Novartis AG's blood cancer drug Tasigna is better at treating a type of chronic myeloid leukaemia than its older drug Glivec, according to data from two late-stage ... Read more
FDA approves Novartis flu vaccine produced by cultured animal cells

FDA approves Novartis flu vaccine produced by cultured animal cells

November 20, 2012 5:25 pm by | 0 Comments

(Reuters) - The U.S. Food and Drug Administration said on Tuesday it approved a seasonal flu vaccine produced by Novartis using cultured animal cells rather than the traditional manufacturing process ... Read more
‘Problem child’ vaccine division gets chance to prove itself for Novartis

‘Problem child’ vaccine division gets chance to prove itself for Novartis

November 16, 2012 11:44 am by | 0 Comments

ZURICH (Reuters) - The European Medicines Agency has thrown Novartis' loss-making vaccines business a lifeline by recommending its meningitis B shot for approval, which means the pressure is on to ... Read more